Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.

Schüring AN, Fehm T, Behringer K, Goeckenjan M, Wimberger P, Henes M, Henes J, Fey MF, von Wolff M.

Arch Gynecol Obstet. 2017 Nov 24. doi: 10.1007/s00404-017-4594-3. [Epub ahead of print]

PMID:
29177593
2.

Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation.

Metzelder SK, Schroeder T, Lübbert M, Ditschkowski M, Götze K, Scholl S, Meyer RG, Dreger P, Basara N, Fey MF, Salih HR, Finck A, Pabst T, Giagounidis A, Kobbe G, Wollmer E, Finke J, Neubauer A, Burchert A.

Eur J Cancer. 2017 Nov;86:233-239. doi: 10.1016/j.ejca.2017.09.016. Epub 2017 Oct 18.

PMID:
29055209
3.

The costs of care in haematological cancers: Health economic issues.

Fey MF.

Hematol Oncol. 2017 Jun;35 Suppl 1:15-19. doi: 10.1002/hon.2394. No abstract available.

PMID:
28591414
4.

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y.

ESMO Open. 2016 Sep 29;1(5):e000097. eCollection 2016. Review.

5.

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.

Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G; ESMO/ASCO Global Curriculum Working Group.

Ann Oncol. 2016 Aug;27(8):1378-81. doi: 10.1093/annonc/mdw239. No abstract available.

6.

MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.

Rothschild SI, Gautschi O, Batliner J, Gugger M, Fey MF, Tschan MP.

Lung Cancer. 2017 May;107:73-83. doi: 10.1016/j.lungcan.2016.06.004. Epub 2016 Jun 14.

PMID:
27372519
7.

The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.

Wampfler J, Federzoni EA, Torbett BE, Fey MF, Tschan MP.

Leuk Res. 2016 Feb;41:96-102. doi: 10.1016/j.leukres.2015.12.006. Epub 2015 Dec 19.

PMID:
26740055
8.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.

Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ, Theobald M, Graux C, Kuball J, Schouten HC, Pabst T, Löwenberg B, Ossenkoppele G, Vellenga E, Cornelissen JJ; HOVON and SAKK Leukemia Groups.

Lancet Haematol. 2015 Oct;2(10):e427-36. doi: 10.1016/S2352-3026(15)00148-9. Epub 2015 Sep 18.

PMID:
26686044
9.

Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells.

Wampfler J, Federzoni EA, Torbett BE, Fey MF, Tschan MP.

J Leukoc Biol. 2015 Sep;98(3):357-63. doi: 10.1189/jlb.1AB0514-258R. Epub 2015 May 19.

10.

Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells.

Federzoni EA, Gloor S, Jin J, Shan-Krauer D, Fey MF, Torbett BE, Tschan MP.

Leuk Res Rep. 2015 Apr 23;4(1):32-5. doi: 10.1016/j.lrr.2015.04.002. eCollection 2015.

11.

[Today's cancer medicine: less could often be more].

Fey MF.

Ther Umsch. 2014 Dec;71(12):765-70. doi: 10.1024/0040-5930/a000623. Review. German.

PMID:
25447092
12.

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.

Cornelissen JJ, Versluis J, Passweg JR, van Putten WL, Manz MG, Maertens J, Beverloo HB, Valk PJ, van Marwijk Kooy M, Wijermans PW, Schaafsma MR, Biemond BJ, Vekemans MC, Breems DA, Verdonck LF, Fey MF, Jongen-Lavrencic M, Janssen JJ, Huls G, Kuball J, Pabst T, Graux C, Schouten HC, Gratwohl A, Vellenga E, Ossenkoppele G, Löwenberg B; HOVON; SAKK Leukemia Groups.

Leukemia. 2015 May;29(5):1041-50. doi: 10.1038/leu.2014.332. Epub 2014 Nov 27.

PMID:
25428261
13.

Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.

Vidal AD, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.

Ann Oncol. 2015 Feb;26(2):374-7. doi: 10.1093/annonc/mdu518. Epub 2014 Nov 12.

PMID:
25392157
14.

Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation.

Haimovici A, Brigger D, Torbett BE, Fey MF, Tschan MP.

Leuk Res. 2014 Sep;38(9):1041-7. doi: 10.1016/j.leukres.2014.06.010. Epub 2014 Jul 1.

PMID:
25043887
15.

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, Bernhard J.

Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Epub 2014 Apr 17. Review.

16.

CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation.

Federzoni EA, Humbert M, Torbett BE, Behre G, Fey MF, Tschan MP.

Sci Rep. 2014 Mar 3;4:4261. doi: 10.1038/srep04261.

17.

Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology.

Stutz E, Gautschi O, Fey MF, Gugger M, Tschan MP, Rothschild SI.

Future Oncol. 2014 Feb;10(2):211-7. doi: 10.2217/fon.13.179.

PMID:
24490607
18.

The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.

Humbert M, Federzoni EA, Britschgi A, Schläfli AM, Valk PJ, Kaufmann T, Haferlach T, Behre G, Simon HU, Torbett BE, Fey MF, Tschan MP.

J Leukoc Biol. 2014 Jan;95(1):83-93. doi: 10.1189/jlb.1112608. Epub 2013 Sep 13.

19.

Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Fey MF, Buske C; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi138-43. doi: 10.1093/annonc/mdt320. Epub 2013 Aug 22. No abstract available.

PMID:
23970018
20.

Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation.

Brigger D, Torbett BE, Chen J, Fey MF, Tschan MP.

Biochem Biophys Res Commun. 2013 Aug 23;438(2):283-8. doi: 10.1016/j.bbrc.2013.07.056. Epub 2013 Jul 24.

Supplemental Content

Loading ...
Support Center